-
Versigent Ltd. (VGNT) PT Raised to $58 at UBS
-
Versigent Ltd. (VGNT) PT Raised to $49 at UBS, Estimates Updated
-
Versigent PLC (VGNT) Reported revenue at $2.21 billion, provides guidance
-
Wolfe Research Starts Versigent Ltd. (VGNT) at Outperform
-
BNP Paribas Exane Starts Versigent Ltd. (VGNT) at Outperform
-
Deutsche Bank Starts Versigent Ltd. (VGNT) at Hold
-
Ford, GM and BorgWarner seen as positive setups ahead of Q1 earnings
-
Evercore ISI Starts Versigent Ltd. (VGNT) at Outperform
-
TD Cowen Starts Versigent Ltd. (VGNT) at Buy
-
UBS Starts Versigent Ltd. (VGNT) at Buy
-
Fox Advisors Starts Versigent Ltd. (VGNT) at Overweight
-
Versigent begins trading on NYSE after spinoff from Aptiv
-
Versigent Set to Join S&P SmallCap 600
-
RBC Capital Starts Versigent Ltd. (VGNT) at Sector Perform

